Oct 2024
Inequality aversion represents the degree of concern for reducing a specified inequality, which can also be interpreted as the value that a given stakeholder places on changes in health inequalities. Information on aversion to inequality is often expressed as inequality aversion parameters, such as the Atkinson index. Such parameters can be applied to forms of equity analysis, including distributional cost-effectiveness analysis (DCEA) that enables researchers to evaluate both the equity and effectiveness of healthcare interventions and the broader impacts of healthcare decisions. Incorporating inequality aversion parameters in DCEA facilitates the exploration of the consequences of different social value judgments when comparing policy options that involve trade-offs between improving total health and reducing health inequality.
Apr 2024
In this webinar, experts will characterize financial toxicity from the patient perspective, suggest potential frameworks for incorporation of financial toxicity into economic evaluation, and discuss areas where further research is necessary.
Sponsored by FIFARMA
Aug 2023
Value-Based Procurement (VBP) is a critical element of a value-based healthcare system, offering a transformative purchase approach that addresses underlying barriers to access to innovative treatments. Unlike the traditional procurement methods that focus primarily on cost containment, VBP considers multiple factors, including the unique circumstances of each country, such as local disease burden, health priorities, infrastructure, supply chain, ability to pay for healthcare, and budget processes.
Jul 2023
This webinar aims to provide insights into the economic evaluation of digital health technology, which presents unique challenges compared to pharmaceuticals, healthcare services, and medical devices. In this webinar, you will learn about the current role of health economics and outcomes research in assessing the value of digital health technologies, as well as the impact of digital health interventions in today’s healthcare systems.
Apr 2023
In this forum, the OSM Special Interest Group has selected leaders in the field of health economics to describe their approach to OSMs. Mohsen Sadatsafavi will introduce the Peer Models Network and PRISM service as part of "Open-access modelling as a companion to open-source modelling” illustrated with an example implemented for Chronic Obstructive Pulmonary Disease (the Evaluation Platform in COPD (EPIC) model.)
Oct 2022
Many health systems in Africa are generally characterized by high burden of out-of-pocket payment by patients at the point of care and increased exposure of clients to catastrophic health payments. However, there are recent moves by many African countries to improve their health financing systems and institute health insurance in a bid to ensure universal health coverage.
Sponsored by FIFARMA
Aug 2022
This is the Second webinar of the Value and Access to Innovation webseries sponsored by FIFARMA. The series are structured around FIFARMA's VAI working group workstreams: (1) Funding: what is the relation between health & the economy and how to ensure the long term healthcare system sustainability, (2) Value: what are the value frameworks used by decision makers in LatAm and what is the impact on patient access, (3) Adoption: how to ensure access for the right patient, to the right treatment, at the right time.
Sponsored by FIFARMA
Jul 2022
This is the first webinar of the Value and Access to Innovation webseries sponsored by FIFARMA. The series are structured around FIFARMA's VAI working group workstreams.
Jun 2022
This webinar will aim to provide an educational opportunity for the ISPOR membership to learn about the methods for conducting distributional cost-effectiveness analysis (DCEA).
Sponsored by AstraZeneca
Jun 2022
For cancer drugs, payers often prefer to make decisions based on overall survival (OS) outcomes. However, it may take many years to collect OS data; this is particularly apparent in early-stage cancer and when an active therapy is highly effective at extending life.
Sponsored by Merck & Co., known as MSD outside the United States and Canada
May 2022
Next-generation sequencing (NGS) is the key to precision medicine in oncology and delivers several benefits across the patient care pathway, from providing patients with a tailored therapeutic strategy, increasing efficiency in healthcare systems delivery of care, resulting in potential cost savings and benefits to future patients.
Apr 2022
Health systems in Asia Pacific regions are under tremendous pressure to deal with the rising costs, unequal access to service, and uneven quality of care. More and more healthcare systems across the region have increasingly embraced a value-based health care (VBHC) agenda. How can we maximize value for money and optimize patient outcomes? How should healthcare be delivered and reimbursed? In light of these issues, this webinar brings together a panel of experts to discuss the current situation of value-based payment in the Asia Pacific region and beyond, challenges and opportunities for VBHC implementation in the region.
Sponsored by Biogen
Apr 2022
This session educates about the specific challenges of rare disease treatments in an HTA and discusses how Real-World Evidence Collection can address the data gap at the time of access decision.
Mar 2022
This session will discuss trends in the HTA/Reimbursement environment in Latin America and the drivers for value-based health care (VBHC) implementation within the region. The potential benefits of VBHC, stakeholders’ roles in VBHC, contextual barriers and facilitators for VBHC implementation, and potential future impact of VBHC to healthcare in the region will be discussed by a panel of speakers.
Sponsored by Medtronic
Mar 2022
Experts from around the world will be sharing their experience about obesity treatment and reimbursement policies in their different countries. The event will consist of 7 expert presentations followed by a round table discussion with an opportunity for the audience to ask questions.
Jan 2022
This webinar led by the task force co-chairs will focus on the main changes from the original CHEERS and a provide a quick live demonstration on how to use it. They will also discuss how a patient and public participation group was involved in the revision process, the resources being developed to support CHEERS 2022, the proposals for its dissemination and the involvement of a wide range of journals in the publication of the statement.
Sponsored by FIFARMA
Apr 2021
Esta sesión, va a explorar modelos potenciales para generar inversiones a corto plazo para la atención en salud en América Latina, ya sea de nuevas fuentes de ingresos, opciones de financiación internacional o, inversionistas del sector privado. Incluiremos experiencias de países de América Latina así como modelos que se han mostrado prometedores en otros contextos, sectores o regiones que pueden contener lecciones aprendidas relevantes.
Feb 2021
In this webinar, expert speakers will explore the current digital healthcare landscape in Asia Pacific including regulatory, value assessment and reimbursement aspects, as well as future directions. Experiences with validation, evidence generation and reimbursement pathways for digital health solutions will be also shared through case studies.
Feb 2021
This webinar will present an insightful exchange on best practices, challenges and opportunities for market access of biosimilars in different regions worldwide.
Dec 2020
This webinar will discuss the rationale for the revision of the original Consolidated Health Economic Evaluation Reporting Standards (CHEERS) reporting guidelines and outline directions for the new reporting standards, as suggested by a Delphi survey.
Nov 2020
Determining resource utilization patterns, treatment and disease-related costs has become an important aspect of health outcomes research to guide health care resource allocation from a payer and policy decision-making perspectives.
Sep 2020
There is growing interest in the use of open source models (OSMs) for cost-effectiveness analysis. In this session, the leaders of a new Special Interest Group (SIG) will introduce the general ISPOR membership to OSMs, providing an overview of some of the perceived benefits and potential barriers to their adoption. The presenters will share the findings of a recent survey, relaying ISPOR members’ experiences and expectations about OSMs. The webinar will be used to help shape the direction of future events and the focus of the SIG.
Apr 2020
This timely webinar will highlight an initiative under development to create an insurance scheme in African countries to provide emergency financing for disease outbreaks. Country-level engagement to tailor the scheme to country needs and costing of outbreak responses to inform estimates of premiums will be specifically addressed.
Apr 2020
ISPOR—the professional society for health economics and outcomes research (HEOR), announced the publication of its 2020 Top 10 HEOR Trends report early this year. In the report, the Society has identified the top 10 HEOR trends that will shape the field and influence healthcare over 2020 and the near future.
Jan 2019
Mar 2014
Apr 2013